308 related articles for article (PubMed ID: 23557706)
1. Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury.
Eid AA; Ford BM; Bhandary B; de Cassia Cavaglieri R; Block K; Barnes JL; Gorin Y; Choudhury GG; Abboud HE
Diabetes; 2013 Aug; 62(8):2935-47. PubMed ID: 23557706
[TBL] [Abstract][Full Text] [Related]
2. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.
Eid AA; Ford BM; Block K; Kasinath BS; Gorin Y; Ghosh-Choudhury G; Barnes JL; Abboud HE
J Biol Chem; 2010 Nov; 285(48):37503-12. PubMed ID: 20861022
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.
Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS
J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025
[TBL] [Abstract][Full Text] [Related]
5. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
Gorin Y; Cavaglieri RC; Khazim K; Lee DY; Bruno F; Thakur S; Fanti P; Szyndralewiez C; Barnes JL; Block K; Abboud HE
Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1276-87. PubMed ID: 25656366
[TBL] [Abstract][Full Text] [Related]
6. Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice.
Liang Y; Liu H; Fang Y; Lin P; Lu Z; Zhang P; Jiao X; Teng J; Ding X; Dai Y
J Cell Mol Med; 2021 Jan; 25(2):1012-1023. PubMed ID: 33332718
[TBL] [Abstract][Full Text] [Related]
7. The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo.
Khazim K; Gorin Y; Cavaglieri RC; Abboud HE; Fanti P
Am J Physiol Renal Physiol; 2013 Sep; 305(5):F691-700. PubMed ID: 23804455
[TBL] [Abstract][Full Text] [Related]
8. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
9. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
[TBL] [Abstract][Full Text] [Related]
10. The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy.
Lu Q; Zhou Y; Hao M; Li C; Wang J; Shu F; Du L; Zhu X; Zhang Q; Yin X
Mol Cell Endocrinol; 2018 Sep; 473():31-43. PubMed ID: 29277549
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.
Eid AA; Gorin Y; Fagg BM; Maalouf R; Barnes JL; Block K; Abboud HE
Diabetes; 2009 May; 58(5):1201-11. PubMed ID: 19208908
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
13. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.
Sedeek M; Callera G; Montezano A; Gutsol A; Heitz F; Szyndralewiez C; Page P; Kennedy CR; Burns KD; Touyz RM; Hébert RL
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1348-58. PubMed ID: 20630933
[TBL] [Abstract][Full Text] [Related]
14. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
15. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
16. High glucose induces Nox4 expression and podocyte apoptosis through the Smad3/ezrin/PKA pathway.
Guo W; Gao H; Pan W; Yu P; Che G
Biol Open; 2021 May; 10(5):. PubMed ID: 33046439
[TBL] [Abstract][Full Text] [Related]
17. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
18. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
[TBL] [Abstract][Full Text] [Related]
19. miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4.
Xu Y; Zhang J; Fan L; He X
Biochem Biophys Res Commun; 2018 Oct; 505(2):339-345. PubMed ID: 30245133
[TBL] [Abstract][Full Text] [Related]
20. Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.
Langer S; Kreutz R; Eisenreich A
J Nephrol; 2016 Dec; 29(6):765-773. PubMed ID: 26733332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
